Abstract
In the USA, larynx cancer affects an estimated 1 in 250 people. Current treatment modalities emphasize obtaining a cure while maximizing the preservation of function and the quality of life. For early larynx cancers (Tis, T1, T2), these treatment options include primary radiotherapy, transoral endoscopic resection, and conservation laryngeal surgery. Current literature reports similar rates of local control and survival among these modalities, such that management decisions should incorporate the stage, extent of disease, and the anticipated functional outcomes within the context of patient social and medical factors. This chapter discusses the epidemiology, presentation, evaluation, and management of early larynx cancers, with a focus on treatment options and functional considerations.
Original language | English (US) |
---|---|
Title of host publication | Head and Neck Cancer |
Subtitle of host publication | Multimodality Management, Second Edition |
Publisher | Springer International Publishing |
Pages | 539-553 |
Number of pages | 15 |
ISBN (Electronic) | 9783319276014 |
ISBN (Print) | 9783319275994 |
DOIs | |
State | Published - Jan 1 2016 |
Keywords
- Conservation laryngeal surgery
- Larynx cancer
- Radiotherapy
- Transoral endoscopic resection
ASJC Scopus subject areas
- General Medicine